Rich Yang

There is no organic scale pathway here.

And also then to make sure that we get to the insulin dosing claim as fast as possible in our next generation product so that we have a product roadmap and pipeline for people with diabetes that don't use insulin and for people with diabetes that are on insulin.

And so we will be partnering with commercial partners to help establish key channels for us and do the heavy lifting around the early evidence with the health systems, large self-insured.

And so there's a huge commitment from our pending potential partners to actually help drive those initiatives, fund those initiatives, because that could lead to more progressive opportunities for some form of reimbursement and expanding the category.

Yes, we're in the first inning.

So we didn't have any legacy architecture for hardware.

We don't have a large installed base of people that need supply reorders today immediately.

And we're at economies of scale with chips and sensors that we can build into the wearable that provides context.

So it made it easy for us.

And our single greatest advantage right now is that we're small and nimble.

So we could take advantage of all of the technologies that are available in the consumer electronics space and put them into our wearables so that we can provide a well-rounded, holistic view.

And that allows us to really deliver a personalized experience.

What we would like to get to is a hyper-personalized experience.

And what I mean by that is we're in the first inning of Biowareables because there's a lot more we can do above and beyond glucose, right?

So Jared has shared in some of our public presentations that

technology conferences that we've done lactate continuously.

We've combined glucose and lactate on a single chip continuously.

We've had our first in humans for cortisol and protein.

So we're in the very, very first inning because once we can combine multiple analytes and it doesn't cost us anything more to add new additional chemistries on our platform because we're the first precision membrane deposition chemistry for a electrochemical sensor.

And the amount of chemistry that's on the tip of these microsensors is really negligible.